Results
|
|
2001.
|
|
|
|
2002.
|
|
|
|
2003.
|
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial. [electronic resource] by
- Carthon, Bradley C
- Wolchok, Jedd D
- Yuan, Jianda
- Kamat, Ashish
- Ng Tang, Derek S
- Sun, Jingjing
- Ku, Geoffrey
- Troncoso, Patricia
- Logothetis, Christopher J
- Allison, James P
- Sharma, Padmanee
Producer: 20100816
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 16
Availability: No items available.
|
|
|
2004.
|
Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes. [electronic resource] by
- Galsky, Matthew D
- Wang, Huan
- Hahn, Noah M
- Twardowski, Przemyslaw
- Pal, Sumanta K
- Albany, Costantine
- Fleming, Mark T
- Starodub, Alexander
- Hauke, Ralph J
- Yu, Menggang
- Zhao, Qianqian
- Sonpavde, Guru
- Donovan, Michael J
- Patel, Vaibhav G
- Sfakianos, John P
- Domingo-Domenech, Josep
- Oh, William K
- Akers, Nicholas
- Losic, Bojan
- Gnjatic, Sacha
- Schadt, Eric E
- Chen, Rong
- Kim-Schulze, Seunghee
- Bhardwaj, Nina
- Uzilov, Andrew V
Producer: 20190214
In:
European urology vol. 73
Availability: No items available.
|
|
|
2005.
|
Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study. [electronic resource] by
- Namikawa, Kenjiro
- Kiyohara, Yoshio
- Takenouchi, Tatsuya
- Uhara, Hisashi
- Uchi, Hiroshi
- Yoshikawa, Shusuke
- Takatsuka, Sumiko
- Koga, Hiroshi
- Wada, Naoko
- Minami, Hironobu
- Hatsumichi, Masahiro
- Asada, Suguru
- Namba, Yoshinobu
- Yamazaki, Naoya
Producer: 20191003
In:
European journal of cancer (Oxford, England : 1990) vol. 105
Availability: No items available.
|
|
|
2006.
|
Phase II study of the immune-checkpoint inhibitor ipilimumab plus dacarbazine in Japanese patients with previously untreated, unresectable or metastatic melanoma. [electronic resource] by
- Yamazaki, N
- Uhara, H
- Fukushima, S
- Uchi, H
- Shibagaki, N
- Kiyohara, Y
- Tsutsumida, A
- Namikawa, K
- Okuyama, R
- Otsuka, Y
- Tokudome, T
Producer: 20160128
In:
Cancer chemotherapy and pharmacology vol. 76
Availability: No items available.
|
|
|
2007.
|
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma. [electronic resource] by
- Bertrand, Florie
- Montfort, Anne
- Marcheteau, Elie
- Imbert, Caroline
- Gilhodes, Julia
- Filleron, Thomas
- Rochaix, Philippe
- Andrieu-Abadie, Nathalie
- Levade, Thierry
- Meyer, Nicolas
- Colacios, Céline
- Ségui, Bruno
Producer: 20181023
In:
Nature communications vol. 8
Availability: No items available.
|
|
|
2008.
|
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy. [electronic resource] by
- Gide, Tuba N
- Quek, Camelia
- Menzies, Alexander M
- Tasker, Annie T
- Shang, Ping
- Holst, Jeff
- Madore, Jason
- Lim, Su Yin
- Velickovic, Rebecca
- Wongchenko, Matthew
- Yan, Yibing
- Lo, Serigne
- Carlino, Matteo S
- Guminski, Alexander
- Saw, Robyn P M
- Pang, Angel
- McGuire, Helen M
- Palendira, Umaimainthan
- Thompson, John F
- Rizos, Helen
- Silva, Ines Pires da
- Batten, Marcel
- Scolyer, Richard A
- Long, Georgina V
- Wilmott, James S
Producer: 20191206
In:
Cancer cell vol. 35
Availability: No items available.
|
|
|
2009.
|
PD-1 blockade therapy in renal cell carcinoma: current studies and future promises. [electronic resource] by
- Massari, F
- Santoni, M
- Ciccarese, C
- Santini, D
- Alfieri, S
- Martignoni, G
- Brunelli, M
- Piva, F
- Berardi, R
- Montironi, R
- Porta, C
- Cascinu, S
- Tortora, G
Producer: 20150406
In:
Cancer treatment reviews vol. 41
Availability: No items available.
|
|
|
2010.
|
Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy. [electronic resource] by
- Danielli, Riccardo
- Cisternino, Filomena
- Giannarelli, Diana
- Calabrò, Luana
- Camerini, Roberto
- Savelli, Vinno
- Bova, Giovanni
- Dragonetti, Rosella
- Di Giacomo, Anna Maria
- Altomonte, Maresa
- Maio, Michele
Producer: 20190111
In:
Expert opinion on biological therapy vol. 18
Availability: No items available.
|
|
|
2011.
|
|
|
|
2012.
|
|
|
|
2013.
|
Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab. [electronic resource] by
- Kwek, Serena S
- Lewis, Jera
- Zhang, Li
- Weinberg, Vivian
- Greaney, Samantha K
- Harzstark, Andrea L
- Lin, Amy M
- Ryan, Charles J
- Small, Eric J
- Fong, Lawrence
Producer: 20160525
In:
Cancer immunology research vol. 3
Availability: No items available.
|
|
|
2014.
|
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma. [electronic resource] by
- Sznol, Mario
- Ferrucci, Pier Francesco
- Hogg, David
- Atkins, Michael B
- Wolter, Pascal
- Guidoboni, Massimo
- Lebbé, Celeste
- Kirkwood, John M
- Schachter, Jacob
- Daniels, Gregory A
- Hassel, Jessica
- Cebon, Jonathan
- Gerritsen, Winald
- Atkinson, Victoria
- Thomas, Luc
- McCaffrey, John
- Power, Derek
- Walker, Dana
- Bhore, Rafia
- Jiang, Joel
- Hodi, F Stephen
- Wolchok, Jedd D
Producer: 20171211
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35
Availability: No items available.
|
|
|
2015.
|
|
|
|
2016.
|
|
|
|
2017.
|
|
|
|
2018.
|
|
|
|
2019.
|
CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells. [electronic resource] by
- Zhou, Jiehua
- Bashey, Asad
- Zhong, Ruikun
- Corringham, Sue
- Messer, Karen
- Pu, Minya
- Ma, Wenxue
- Chut, Theresa
- Soiffer, Robert
- Mitrovich, Rachel C
- Lowy, Israel
- Ball, Edward D
Producer: 20110823
In:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 17
Availability: No items available.
|
|
|
2020.
|
Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials. [electronic resource] by
- Schadendorf, Dirk
- Wolchok, Jedd D
- Hodi, F Stephen
- Chiarion-Sileni, Vanna
- Gonzalez, Rene
- Rutkowski, Piotr
- Grob, Jean-Jacques
- Cowey, C Lance
- Lao, Christopher D
- Chesney, Jason
- Robert, Caroline
- Grossmann, Kenneth
- McDermott, David
- Walker, Dana
- Bhore, Rafia
- Larkin, James
- Postow, Michael A
Producer: 20171211
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35
Availability: No items available.
|